Page last updated: 2024-11-04
threo-alpha-methylisocitrate
Description
threo-alpha-methylisocitrate: RN given refers to cpd without specific stereochemistry; designated cpd not in Chemline 11/1/79 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
3-hydroxybutane-1,2,3-tricarboxylic acid : A tricarboxylic acid that is butan-2-ol in which a hydrogen from each of positions 2, 3, and 4 has been replaced by carboxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 513 |
CHEBI ID | 142525 |
SCHEMBL ID | 321093 |
MeSH ID | M0075516 |
Synonyms (18)
Synonym |
3-hydroxy-1,2,3-butanetricarboxylate |
8518ec1z2e , |
1,2,3-butanetricarboxylic acid, 3-hydroxy- |
unii-8518ec1z2e |
dl-threo-alpha-methylisocitrate |
alpha-methylisocitrate |
threo-alpha-methylisocitrate |
d.l-methylisocitrate |
6061-95-6 |
CHEBI:142525 |
3-hydroxybutane-1,2,3-tricarboxylic acid |
3-carboxy-2,3-dideoxy-4-c-methylpentaric acid |
SCHEMBL321093 |
(2r,3s)2-methylisocitrate |
dl-methylisocitric acid |
3-hydroxy-1,2,3-butanetricarboxylic acid |
methyl isocitric acid |
DTXSID20976051 |
Drug Classes (3)
Class | Description |
tricarboxylic acid | An oxoacid containing three carboxy groups. |
methylisocitric acid | A tricarboxylic acid that is isocitric acid substituted by a methyl group alpha- to one of the carboxylic acid groups. |
tertiary alcohol | A tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.23
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.23 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.18 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |